These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 34418708)

  • 21. Guillain-Barre syndrome following COVID-19 vaccines: A scoping review.
    Lahoz Fernandez PE; Miranda Pereira J; Fonseca Risso I; Baleeiro Rodrigues Silva P; Freitas Barboza IC; Vieira Silveira CG; Diogo Silva G; Marzorati Kuntz Puglia P; Genaro Mutarelli E
    Acta Neurol Scand; 2022 Apr; 145(4):393-398. PubMed ID: 34967005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-world data on the incidence and risk of Guillain-Barré syndrome following SARS-CoV-2 vaccination: a prospective surveillance study.
    Ha J; Park S; Kang H; Kyung T; Kim N; Kim DK; Kim H; Bae K; Song MC; Lee KJ; Lee E; Hwang BS; Youn J; Seok JM; Park K
    Sci Rep; 2023 Mar; 13(1):3773. PubMed ID: 36882454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post coronavirus disease-2019 vaccination Guillain-Barré syndrome.
    Biswas A; Pandey SK; Kumar D; Vardhan H
    Indian J Public Health; 2021; 65(4):422-424. PubMed ID: 34975092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Case Report of Guillain-Barré Syndrome In Association with SARS-CoV-2 Vaccination in Malaysia.
    Sii HL; Ng SH; Wong VF; Law WC
    Acta Neurol Taiwan; 2023 Dec; 32(4)():207-211. PubMed ID: 37723913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform.
    Walker JL; Schultze A; Tazare J; Tamborska A; Singh B; Donegan K; Stowe J; Morton CE; Hulme WJ; Curtis HJ; Williamson EJ; Mehrkar A; Eggo RM; Rentsch CT; Mathur R; Bacon S; Walker AJ; Davy S; Evans D; Inglesby P; Hickman G; MacKenna B; Tomlinson L; Ca Green A; Fisher L; Cockburn J; Parry J; Hester F; Harper S; Bates C; Evans SJ; Solomon T; Andrews NJ; Douglas IJ; Goldacre B; Smeeth L; McDonald HI
    Vaccine; 2022 Jul; 40(32):4479-4487. PubMed ID: 35715350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guillain-Barré syndrome in association with COVID-19 vaccination: a systematic review.
    Abolmaali M; Rezania F; Behnagh AK; Hamidabad NM; Gorji A; Mirzaasgari Z
    Immunol Res; 2022 Dec; 70(6):752-764. PubMed ID: 36098903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of Guillain-Barré syndrome following SARS-CoV-2 immunization: Analysis of a nationwide registry of recipients of 81 million doses of seven vaccines.
    García-Grimshaw M; Galnares-Olalde JA; Bello-Chavolla OY; Michel-Chávez A; Cadena-Fernández A; Briseño-Godínez ME; Antonio-Villa NE; Núñez I; Gutiérrez-Romero A; Hernández-Vanegas L; Del Mar Saniger-Alba M; Carrillo-Mezo R; Ceballos-Liceaga SE; Carbajal-Sandoval G; Flores-Silva FD; Díaz-Ortega JL; Cortes-Alcalá R; Pérez-Padilla JR; López-Gatell H; Chiquete E; Reyes-Terán G; Arauz A; Valdés-Ferrer SI
    Eur J Neurol; 2022 Nov; 29(11):3368-3379. PubMed ID: 35841212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guillain-Barré syndrome after COVID-19 vaccination.
    McKean N; Chircop C
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34330729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rare cases of Guillain-Barré syndrome after COVID-19 vaccination, Germany, December 2020 to August 2021.
    Lehmann HC; Oberle D; Keller-Stanislawski B; Rieck T; Streit R
    Euro Surveill; 2023 Jun; 28(24):. PubMed ID: 37318764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post COVID-19 vaccination Guillain-Barre syndrome: three cases.
    Tabatabaee S; Rezania F; Alwedaie SMJ; Malekdar E; Badi Z; Tabatabaei SM; Mirzaasgari Z
    Hum Vaccin Immunother; 2022 Nov; 18(5):2045153. PubMed ID: 35240922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 vaccine-related Guillain-Barré syndrome in the Liguria region of Italy: A multicenter case series.
    Germano F; Bellucci M; Grisanti S; Beronio A; Grazzini M; Coco E; Tassinari T; Della Cava F; De Michelis C; Baldi O; Sivori G; Murialdo A; Cabona C; Durando P; Uccelli A; Schenone A; Franciotta D; Benedetti L
    J Neurol Sci; 2022 Sep; 440():120330. PubMed ID: 35802961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute-onset chronic inflammatory demyelinating polyneuropathy following AstraZeneca COVID-19 vaccine: a case report.
    Smaoui E; Moalla KS; Bouattour N; Farhat N; Sakka S; Daoud S; Damak M; Mhiri C
    Pan Afr Med J; 2024; 47():46. PubMed ID: 38681104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guillain-Barre Syndrome After Two COVID-19 Vaccinations: Two Case Reports With Follow-up Electrodiagnostic Study.
    Kim JW; Kim YG; Park YC; Choi S; Lee S; Min HJ; Kim MJ
    J Korean Med Sci; 2022 Feb; 37(7):e58. PubMed ID: 35191234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case of Guillain-Barré syndrome following COVID-19 vaccine.
    Hasan T; Khan M; Khan F; Hamza G
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34187803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guillain-Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain-Barré syndrome.
    Ling L; Bagshaw SM; Villeneuve PM
    CMAJ; 2021 Nov; 193(46):E1766-E1769. PubMed ID: 34810163
    [No Abstract]   [Full Text] [Related]  

  • 36. Association Between Guillain-Barré Syndrome and COVID-19 Infection and Vaccination: A Population-Based Nested Case-Control Study.
    Bishara H; Arbel A; Barnett-Griness O; Bloch S; Cohen S; Najjar-Debbiny R; Gronich N; Auriel E; Saliba W
    Neurology; 2023 Nov; 101(20):e2035-e2042. PubMed ID: 37852786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guillain-Barré Syndrome Associated with COVID-19 Vaccination.
    Finsterer J; Scorza FA; Scorza CA
    Emerg Infect Dis; 2022 May; 28(5):1079-1080. PubMed ID: 35447058
    [No Abstract]   [Full Text] [Related]  

  • 38. Sensory Ataxic Guillain-Barré Syndrome with Dysgeusia after mRNA COVID-19 Vaccination.
    Ogata S; Ishii Y; Asano K; Kobayashi E; Kubota S; Takahashi K; Miyaji Y; Higashiyama Y; Joki H; Doi H; Koga M; Takeuchi H; Tanaka F
    Intern Med; 2022 Jun; 61(11):1757-1760. PubMed ID: 35342134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory demyelinating polyneuropathy after the ChAdOx1 nCoV-19 vaccine may follow a chronic course.
    de Souza A; Oo WM; Giri P
    J Neurol Sci; 2022 May; 436():120231. PubMed ID: 35313224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comment on "SARS-CoV-2 vaccinations may not only be complicated by GBS but also by distal small fiber neuropathy by J. Finsterer.
    Galassi G
    J Neuroimmunol; 2022 Aug; 369():577901. PubMed ID: 35667183
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.